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Introduction {#acr23419-sec-0005}
============

Pain, fatigue, and depression [1](#acr23419-bib-0001){ref-type="ref"} in many cases lead to activity limitation [2](#acr23419-bib-0002){ref-type="ref"} and are common among persons with rheumatoid arthritis (RA). Better use of disease‐modifying drugs, including biologics, during the past decades has improved inflammation control and the course of disease [1](#acr23419-bib-0001){ref-type="ref"}, [3](#acr23419-bib-0003){ref-type="ref"}, but many persons under treatment still report pain and fatigue [1](#acr23419-bib-0001){ref-type="ref"}. Persons with RA also experience an increased risk of cardiovascular comorbidity, partly due to the disease‐specific inflammatory processes [4](#acr23419-bib-0004){ref-type="ref"}.Significance & InnovationsDistinct 2‐year trajectories of fear‐avoidance beliefs on physical activity can be identified in persons with rheumatoid arthritis.Stable, high fear‐avoidance is predicted by high activity limitation, male sex, income below average, not performing health‐enhancing physical activity, and elevated levels of anxiety/depression.Fear‐avoidance may be targeted more effectively by tailoring physical activity promotion to vulnerable socioeconomic groups, men, and those with high activity limitation and anxiety/depression.

To address disease symptoms and the increased risk of cardiovascular comorbidity, sufficient physical activity, including aerobic exercise and muscle‐strength training, is recommended [5](#acr23419-bib-0005){ref-type="ref"}. Health‐enhancing physical activity (HEPA) is generally defined as a minimum of 150 weekly minutes of moderate, or 75 weekly minutes of intense, physical activity with the addition of muscle strength training twice a week [6](#acr23419-bib-0006){ref-type="ref"}. The HEPA recommendations are similar for populations with and without long‐term health conditions such as RA [6](#acr23419-bib-0006){ref-type="ref"}.

Despite the beneficial effects of HEPA, many persons with RA do not reach or maintain the recommended HEPA levels [7](#acr23419-bib-0007){ref-type="ref"}, [8](#acr23419-bib-0008){ref-type="ref"}. To explore and potentially influence physical activity behavior, numerous correlates have been identified in the general population [9](#acr23419-bib-0009){ref-type="ref"} and in RA [10](#acr23419-bib-0010){ref-type="ref"}. For people with RA, psychological and contextual variables seem to be stronger correlates of physical activity than disease‐related and sociodemographic ones [8](#acr23419-bib-0008){ref-type="ref"}, [10](#acr23419-bib-0010){ref-type="ref"}, [11](#acr23419-bib-0011){ref-type="ref"}. Self‐efficacy, defined as a person\'s confidence in performing a specific behavior [12](#acr23419-bib-0012){ref-type="ref"}, and motivation for being physically active are 2 important psychological determinants [8](#acr23419-bib-0008){ref-type="ref"}, [10](#acr23419-bib-0010){ref-type="ref"}, [11](#acr23419-bib-0011){ref-type="ref"}.

Fear‐avoidance belief about pain and its consequences is one psychological variable found to predict long‐term disability [13](#acr23419-bib-0013){ref-type="ref"} and to moderate treatment effects [14](#acr23419-bib-0014){ref-type="ref"} in subacute nonspecific back pain. A theoretical model based on clinical observations of patients with persistent pain describes the role of fear‐avoidance as part of a vicious cycle of psychological and behavioral events. Negative appraisal of pain due to negative affectivity and/or threatening illness information may lead to catastrophic cognitions about the worst possible outcome. This negative appraisal leads to fear, avoidant behaviors, and hypervigilance to bodily sensations, followed by disuse, depression, and disability, which in turn maintain the pain experience, fear, and avoidance [15](#acr23419-bib-0015){ref-type="ref"}, [16](#acr23419-bib-0016){ref-type="ref"}. Intervention studies indicate that it is possible to affect fear‐avoidance by use of graded exposure treatment in patients with long‐term back pain [17](#acr23419-bib-0017){ref-type="ref"}, [18](#acr23419-bib-0018){ref-type="ref"}, [19](#acr23419-bib-0019){ref-type="ref"} and complex regional pain syndromes [20](#acr23419-bib-0020){ref-type="ref"}. Such treatment includes patient education and systematic exposure to feared activities with gradually increasing difficulty, tailored to each patient [20](#acr23419-bib-0020){ref-type="ref"}. Progressive, person‐centered resistance exercise has also proven effective in reducing fear‐avoidance beliefs in women with fibromyalgia [21](#acr23419-bib-0021){ref-type="ref"}. However, if not addressed with appropriate treatment, fear‐avoidance beliefs seem persistent in patients with chronic low back pain, while they are spontaneously reduced over time in patients with acute back pain [22](#acr23419-bib-0022){ref-type="ref"}.

In RA, the role of fear‐avoidance and its development over time have been minimally explored and the few existing studies are inconclusive, reporting positive correlations with pain intensity [23](#acr23419-bib-0023){ref-type="ref"}, [24](#acr23419-bib-0024){ref-type="ref"} but not with physical activity [24](#acr23419-bib-0024){ref-type="ref"}, [25](#acr23419-bib-0025){ref-type="ref"}. RA is a long‐term condition, characterized by unpredictable flares and remissions with subsequent variations in pain, that also affects many other physical, psychological, and contextual aspects of health and functioning. Thus, a wide approach based on the fear‐avoidance model and longitudinal data would benefit a better understanding of the role of fear‐avoidance beliefs and their development over time in people with RA.

The development of fear‐avoidance beliefs may be described by presenting changes in mean levels over time in a total sample. However, such analyses do not take into account that several different patterns may coexist within that sample, and consequently a major part of the potential heterogeneity in fear‐avoidance may not be identified or explained. An alternative method is to identify a number of clinically relevant patterns using longitudinal cluster analysis. Such analyses identify groups of individuals, defined by a specific pattern, or trajectory, over time [26](#acr23419-bib-0026){ref-type="ref"}. To our knowledge, no previous study has investigated trajectories of fear‐avoidance beliefs over time in a large, well‐defined sample of people with RA. The aim of the present study was to identify and describe groups displaying different trajectories of fear‐avoidance beliefs over 2 years and to identify biopsychosocial, theory‐based baseline predictors for each trajectory in a large cohort of people with RA.

Subjects And Methods {#acr23419-sec-0006}
====================

Design {#acr23419-sec-0007}
------

This longitudinal study used data from the Swedish Rheumatology Quality registers, which at the time of data collection (2010) included approximately 27,000 individuals with RA. Six rheumatology clinics were selected to represent university hospitals (n = 2) and county hospitals (n = 4) in different parts of Sweden.

Participants {#acr23419-sec-0008}
------------

The 6 participating clinics had 9,560 registered patients diagnosed with RA according to the 1987 criteria from the American College of Rheumatology [27](#acr23419-bib-0027){ref-type="ref"}. Inclusion criteria were ages ≤75 years and a Stanford Health Assessment Questionnaire disability index (HAQ DI) of ≤2.0. After additional exclusion of registered patients who had died (n = 164), emigrated (n = 24), or had protected identity (n = 14), 5,391 eligible individuals were mailed a questionnaire. Of these, 3,152 answered and were mailed the same questionnaire again 14 and 26 months later. The present study sample includes the 2,569 individuals completing the questionnaire at least twice: at baseline and at 14 and/or 26 months.

Measures {#acr23419-sec-0009}
--------

### Dependent variable {#acr23419-sec-0010}

Fear‐avoidance beliefs were assessed with a subscale from the Fear‐Avoidance Beliefs Questionnaire (FABQ), consisting of the following 4 items on beliefs about physical activity causing pain and injury: pain is caused by physical activity, physical activity makes one\'s pain worse, physical activity might be harmful, and one should not do physical activity that might worsen one\'s pain. These 4 items constitute the physical activity subscale (FABQ‐PA), identified through principal component analysis of the original 16‐item FABQ [28](#acr23419-bib-0028){ref-type="ref"}. Ratings are given on 0--6 scales, where 0 = do not agree at all and 6 = agree completely, with a sum score of 0--24. Values over 15 on FABQ‐PA have been suggested to indicate high fear‐avoidance [29](#acr23419-bib-0029){ref-type="ref"} and cutoffs between 14 and 16 have been used to dichotomize samples in previous studies [30](#acr23419-bib-0030){ref-type="ref"}, [31](#acr23419-bib-0031){ref-type="ref"}. FABQ has demonstrated good test--retest reliability and internal consistency in patients with acute low‐back pain [32](#acr23419-bib-0032){ref-type="ref"}.

### Independent variables {#acr23419-sec-0011}

Sociodemographic data on sex and age were retrieved from the Swedish Rheumatology Quality registers. Data on education, income, number of children and adults in the household, and all additional data were collected by postal questionnaires.

Disease‐related data on comorbidity were assessed by number and name of additional diagnoses besides RA. Pain, fatigue, and general health perception were rated on visual analog scales (range 0--100), where 100 indicated the worst condition. For the analyses, pain was categorized as 0--29, 30--54, and 55--100 according to Collins et al [33](#acr23419-bib-0033){ref-type="ref"}, while fatigue and general health were divided into tertiles based on the distribution of the present sample. Activity limitation was assessed by the HAQ DI, which includes 20 items. Eight activities of daily living (e.g., dressing, eating, and performing hygiene) were rated on a 0--3 scale, where 0 = without difficulty and 3 = unable to do. A total HAQ DI score was created by calculating the mean of the 20 items. The score was categorized into 3 groups for analysis (0, 0.1--1.0, or \>1.0) as HAQ 1.0 and above indicates difficulties in every activity of daily living [34](#acr23419-bib-0034){ref-type="ref"}. Anxiety and depression were assessed by 1 item from the EuroQoL 5‐domain questionnaire (EQ‐5D) [35](#acr23419-bib-0035){ref-type="ref"} where 1 = "I am not anxious or depressed," 2 = "I am moderately anxious or depressed," and 3 = "I am extremely anxious or depressed." EQ‐5D has demonstrated satisfactory concurrent validity by high correlations with disability measures in RA [36](#acr23419-bib-0036){ref-type="ref"}.

Self‐efficacy for exercise was assessed by the Exercise Self‐Efficacy Scale (ESES) using the stem "How confident are you to exercise..." followed by 6 items describing common barriers for exercise, e.g., when physically fatigued. Ratings are given on a 1--6 scale, where 1 = not at all confident and 6 = very confident, adding up to a total score with a range of 6--36. The ESES is reported to have sufficient internal consistency and concurrent validity [37](#acr23419-bib-0037){ref-type="ref"}. Tertiles based on the present sample distribution were created for analysis.

Current HEPA was assessed using the short version of the International Physical Activity Questionnaire (IPAQ). This questionnaire includes items on physical activity at 3 intensity levels (vigorous, moderate, and walking) and 4 domains (work, home, transportation, and leisure time). The short version has acceptable test--retest reliability and criterion‐related validity compared to accelerometers [38](#acr23419-bib-0038){ref-type="ref"}. Minutes of vigorous, moderate, and walking intensity activity per week were summed and converted to hours per week for each individual. Based on the IPAQ data, we created the dichotomous variable Current HEPA, indicating whether the recommendations on total moderately/vigorously intense physical activity (150 minutes of moderate intensity or 75 minutes of vigorous intensity plus 2 muscle‐strength training sessions) during the past week were met or not. Maintained HEPA was assessed using the Exercise Stage Assessment Instrument (ESAI) [39](#acr23419-bib-0039){ref-type="ref"}, which was modified from 1--2 items to suit the present study. The first item defines performance of aerobic physical activity as that of moderate intensity during a minimum of 30 minutes at least 5 times per week. The second item defines performance of muscle strength training as resistance training at least twice a week. Both items are followed by the question: "Are you physically active according to this description?" Five response options are given, based on the stages in the Transtheoretical Model [40](#acr23419-bib-0040){ref-type="ref"}: "No, and I don\'t intend to be within the next six months," "No, but I intend to be within the next six months," "No, but I intend to be within the next 30 days," "Yes, and I have been for less than six months," and "Yes, I have been for six months or longer." To be coded as maintained HEPA, the last response option was required for both items. All other combinations were coded as not maintained HEPA. The original ESAI has demonstrated sufficient test--retest reliability [41](#acr23419-bib-0041){ref-type="ref"} and construct validity with other exercise stage‐of‐change measures [42](#acr23419-bib-0042){ref-type="ref"}.

Statistical analysis {#acr23419-sec-0012}
--------------------

Descriptive data were calculated for the whole sample at baseline using means and SDs or percentages, as appropriate. K‐means cluster analysis for longitudinal data, using the KmL [26](#acr23419-bib-0026){ref-type="ref"} package in R [43](#acr23419-bib-0043){ref-type="ref"}, was used to identify distinct trajectories of fear‐avoidance beliefs, which were measured 3 times (at baseline, 14‐ and 26‐month followup). In brief, the K‐means method for cluster analysis begins by randomly assigning each individual participant\'s trajectory of fear‐avoidance beliefs into one of the K groups. A model is fit to each group to create 1 trajectory to represent each of the K groups. The distance between each individual trajectory and group trajectory is calculated, and participants are moved to the closest group. This algorithm is then repeated until all individual participant trajectories stop moving. As cluster analysis requires a priori specification of the number of clusters (K), the analysis was run 4 times with a priori numbers of clusters from 2 to 5. To assess model fit, the Calinski‐Harabasz criterion, which is a ratio of between‐cluster means and within‐cluster covariance, along with consideration of clinical relevance, was used to select the number of clusters that best fit the data.

Multinomial logistic regression was then used to calculate odds ratios and 95% confidence intervals for the association between potential predictors of trajectory membership and each trajectory, with trajectory as the outcome. Correlations among potential predictors were examined to assure absence of collinearity.

Missing data were \<5% in all variables except for self‐efficacy for exercise, which had 10% missing. Multiple imputation was used to impute missing data in potential predictors for the multinomial logistic regression, which included sociodemographic, disease‐related, self‐efficacy, and physical activity variables. Analyses were performed with and without imputed data. As similar results were seen in imputed versus nonimputed analyses, we present the results using the imputed data.

The study was carried out in compliance with the Helsinki Declaration. Ethical approval was obtained from the Stockholm Regional Ethical Review Board (2010/1232‐31/1 and 2011/1241‐32). Participants were invited to the study in an information letter, and they consented by returning their completed questionnaires.

Results {#acr23419-sec-0013}
=======

Three distinct, stable trajectories of fear‐avoidance beliefs deemed to be of clinical relevance were identified. These trajectories represented a low group (n = 1,060, 41%) with average FABQ‐PA of 3, a moderate group (n = 1,043, 41%) with average FABQ‐PA of 9, and a high group (n = 466, 18%), with average FABQ‐PA of 15 (Figure [1](#acr23419-fig-0001){ref-type="fig"}). Baseline descriptive data for the total sample (n = 2,569) and separately by the 3 trajectories are shown in Table [1](#acr23419-tbl-0001){ref-type="table-wrap"}, demonstrating differences between groups in all included potential predictors except number of adults in household (*P* = 0.362).

![Three trajectories of fear‐avoidance beliefs identified by K‐means cluster analysis: A = low (41% of the total sample), B = moderate (41% of the total sample), and C = high (18% of the total sample). Total sample n = 2,569. Values indicate the average over a 2‐year period. FABQ‐PA = Fear‐Avoidance Beliefs Questionnaire physical activity subscale.](ACR-70-695-g001){#acr23419-fig-0001}

###### 

Baseline characteristics for the total study sample, low (n = 1,060), moderate (n = 1,043), and high (n = 466) fear‐avoidance groups[a](#acr23419-note-0003){ref-type="fn"}

                                                                                       Total                Low                  Moderate             High               *P*
  ------------------------------------------------------------------------------------ -------------------- -------------------- -------------------- ------------------ -----------
  Sex, no.                                                                             2,569                1,060                1,043                466                --
  Women                                                                                1875 (73)            817 (77)             761 (73)             297 (64)           \< 0.0001
  Men                                                                                  694 (27)             243 (23)             282 (27)             169 (36)           --
  Age, no. (mean ± SD)                                                                 2,569 (60 ± 11)      1,060 (58 ± 12)      1,043 (59 ± 10.8)    466 (62 ± 9)       \< 0.0001
  18--34                                                                               90 (4)               51 (5)               35 (3)               4 (1)              \< 0.0001
  35--54                                                                               624 (24)             285 (27)             250 (24)             89 (19)            --
  ≥55                                                                                  1,873 (73)           724 (68)             758 (73)             373 (80)           --
  Education, no.                                                                       1,746                1,054                1,035                457                --
  University                                                                           888 (50)             473 (45)             321 (31)             94 (21)            \< 0.0001
  College                                                                              672 (15)             252 (24)             279 (27)             141 (31)           --
  Other                                                                                300 (17)             110 (10)             147 (14)             43 (9)             --
  Basic                                                                                686 (39)             219 (21)             288 (28)             179 (39)           --
  Swedish average income, no.                                                          2,510                1,044                1,017                449                --
  Below                                                                                1,256 (50)           403 (39)             530 (52)             323 (72)           \< 0.0001
  Above                                                                                1,254 (50)           641 (61)             487 (48)             126 (28)           --
  Ages \<18 years, no.                                                                 2,550                1,053                1,037                460                --
  0                                                                                    2,138 (84)           855 (81)             885 (85)             398 (87)           0.002
  1                                                                                    189 (7)              82 (8)               76 (7)               31 (7)             --
  ≥2                                                                                   223 (9)              116 (11)             76 (7)               31 (7)             --
  Additional adults in household, no.                                                  2,498                1,054                1,033                456                --
  0                                                                                    578 (23)             232 (22)             230 (22)             116 (25)           0.362
  1                                                                                    1,620 (65)           694 (66)             681 (66)             290 (64)           --
  2--3                                                                                 276 (11)             118 (11)             112 (11)             46 (10)            --
  \>3                                                                                  24 (1)               10 (1)               10 (1)               4 (1)              --
  Comorbidities, no.[b](#acr23419-note-0004){ref-type="fn"}                            2,569                1,060                1,043                466                --
  0                                                                                    1,139 (44)           561 (53)             426 (41)             152 (33)           \< 0.0001
  1                                                                                    437 (17)             176 (17)             185 (18)             76 (16)            --
  ≥2                                                                                   993 (39)             323 (30)             432 (41)             238 (51)           --
  Pain, no. (mean ± SD)[c](#acr23419-note-0005){ref-type="fn"}                         2,563 (32 ± 25)      1,059 (21 ± 21)      1,039 (36 ± 24)      465 (48 ± 25)      \< 0.0001
  Low (0--29)                                                                          1,389 (54)           790 (75)             469 (45)             130 (28)           \< 0.0001
  Moderate (30--54)                                                                    594 (23)             167 (16)             297 (29)             130 (28)           --
  High (\>55)                                                                          580 (23)             102 (10)             273 (26)             205 (44)           --
  Fatigue, no. (mean ± SD)[c](#acr23419-note-0005){ref-type="fn"}                      2,149 (39 ± 27)      1,059 (28 ± 24)      1,037 (43 ± 25)      465 (53 ± 25)      \< 0.0001
  Low, lowest tertile                                                                  890 (41)             532 (50)             283 (27)             75 (16)            \< 0.0001
  Moderate, middle tertile                                                             861 (40)             341 (32)             373 (36)             147 (32)           --
  High, highest tertile                                                                810 (38)             186 (18)             381 (37)             243 (52)           --
  Health, no. (mean ± SD)[c](#acr23419-note-0005){ref-type="fn"}                       2,513 (34 ± 25)      1,041 (23 ± 23)      1,019 (37 ± 23)      453 (50 ± 24)      \< 0.0001
  Good, lowest tertile                                                                 885 (35)             558 (54)             269 (26)             58 (13)            \< 0.0001
  Moderate, middle tertile                                                             852 (34)             315 (30)             381 (37)             129 (28)           --
  Poor, highest tertile                                                                803 (32)             168 (16)             369 (36)             266 (59)           --
  Activity limitation, no. (mean ± SD)[d](#acr23419-note-0006){ref-type="fn"}          2,556 (0.62 ± 0.6)   1,054 (0.35 ± 0.4)   1,043 (0.70 ± 0.6)   462 (1.01 ± 0.6)   \< 0.0001
  Low, 0                                                                               649 (25)             437 (41)             178 (17)             34 (7)             \< 0.0001
  Moderate, 0.1--1.0                                                                   1,348 (53)           528 (50)             592 (57)             228 (49)           --
  High, 1.1--3.0                                                                       562 (22)             89 (8)               273 (26)             200 (43)           --
  Anxiety/depression, no.[e](#acr23419-note-0007){ref-type="fn"}                       2,558                1,055                1,040                463                --
  Low, no anxiety/depression                                                           1,677 (66)           807 (76)             651 (63)             219 (47)           \< 0.0001
  Moderate, to some extent                                                             835 (33)             241 (23)             372 (36)             222 (48)           --
  High, extremely                                                                      46 (2)               7 (1)                17 (2)               22 (5)             --
  Self‐efficacy for exercise, no. (mean ± SD)[f](#acr23419-note-0008){ref-type="fn"}   2,303 (31 ± 13)      968 (35 ± 13)        940 (29 ± 12)        395 (27 ± 13)      \< 0.0001
  Low, lowest tertile                                                                  760 (33)             251 (26)             336 (36)             173 (44)           \< 0.0001
  Moderate, middle tertile                                                             733 (32)             272 (28)             332 (35)             129 (33)           --
  High, highest tertile                                                                810 (35)             445 (46)             272 (29)             93 (24)            --
  Current HEPA, no.[g](#acr23419-note-0009){ref-type="fn"}                             2,560                1,056                1,039                465                --
  Yes, \>150 minutes                                                                   1,829 (71)           855 (81)             718 (69)             256 (55)           \< 0.0001
  No, \<150 minutes                                                                    731 (29)             201 (19)             321 (31)             209 (45)           --
  Maintained HEPA, no.[h](#acr23419-note-0010){ref-type="fn"}                          2,432                1,010                987                  435                --
  Yes, \>6 months                                                                      284 (12)             166 (16)             88 (9)               30 (7)             \< 0.0001
  No, \<6 months                                                                       2,148 (88)           844 (84)             899 (91)             405 (93)           --

Values are the number (%) unless indicated otherwise. Comparisons between all 3 groups are based on chi square test or unpaired *t*‐test. Where numbers do not add up to the number of total group size (2,769, 1,060, 1,043, 466), there are missing data. VAS = visual analog scale; HAQ DI = Health Assessment Questionnaire disability index; EQ‐5D = EuroQoL 5‐domain questionnaire; ESES = Exercise Self‐Efficacy Scale; HEPA = health‐enhancing physical activity; IPAQ = International Physical Activity Questionnaire; ESAI = Exercise Stage Assessment Instrument.

Predominantly cardiovascular disease, lung disease, and additional musculoskeletal conditions.

Measured by VAS, range 0--100.

Measured by HAQ DI, range 0--3.

Measured by EQ‐5D.

Measured by ESES, range 6--60.

Measured by IPAQ.

Measured by ESAI.
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The results are presented by contrasting the high group versus the moderate and the low fear‐avoidance groups. Consistent predictors (i.e., demonstrating high odds ratio values and distinguishing the trajectory with high fear‐avoidance from the other 2 trajectories) of being in the high group were high activity limitation, male sex, income below average, not performing HEPA, and anxiety/depression. Being in the high versus the low group was predicted by education below university level, high pain intensity, moderate anxiety/depression, and low self‐efficacy for exercise. The results for all potential predictors of being in the high versus the other 2 groups are shown in Table [2](#acr23419-tbl-0002){ref-type="table-wrap"}.

###### 

Baseline predictors of being in the high (n = 466) fear‐avoidance trajectory versus the low (n = 1,060) and the moderate (n = 1,043) trajectories based on multinomial logistic regression analysis[a](#acr23419-note-0011){ref-type="fn"}

                                           High vs low          High vs moderate                        
  ---------------------------------------- -------------------- ------------------ -------------------- -----------
  Women vs. men                            0.30 (0.22--0.41)    \< 0.0001          0.51 (0.39--0.67)    \< 0.0001
  Ages 35--54 vs. 18--34, years            3.17 (1.01--9.96)    0.049              3.08 (1.01--9.37)    0.048
  Ages \>55 vs. 18--34, years              3.01 (0.95--9.47)    0.06               4.04 (1.32--12.35)   0.015
  Education                                                                                             
  High school vs. university               1.84 (1.29--2.62)    0.001              1.33 (0.96--1.85)    0.089
  Other vs. university                     1.11 (0.68--1.80)    0.672              0.71 (0.46--1.11)    0.137
  Basic vs. university                     1.99 (1.38--2.86)    0.0002             1.34 (0.96--1.87)    0.085
  Income above vs. below Swedish average   0.42 (0.31--0.57)    \< 0.0001          0.50 (0.38--0.65)    \< 0.0001
  Children \<18 years 1 vs. 0              1.71 (0.99--2.98)    0.056              1.52 (0.92--2.51)    0.102
  Children \<18 years 2+ vs. 0             1.53 (0.86--2.71)    0.146              1.89 (1.09--3.25)    0.023
  Comorbidities 1 vs. 0                    1.31 (0.90--1.90)    0.160              1.04 (0.74--1.48)    0.804
  Comorbidities ≥2 vs. 0                   1.45 (1.08--1.95)    0.014              1.12 (0.86--1.47)    0.399
  Pain VAS, moderate vs. low               1.65 (1.10--2.46)    0.015              0.93 (0.64--1.35)    0.707
  Pain VAS, high vs. low                   2.58 (1.58--4.22)    0.0001             1.22 (0.79--1.87)    0.370
  Fatigue VAS, moderate vs. low            1.25 (0.85--1.85)    0.256              1.04 (0.71--1.52)    0.831
  Fatigue VAS, high vs. low                1.47 (0.94--2.31)    0.094              1.09 (0.71--1.67)    0.687
  Health VAS, moderate vs. poor            1.34 (0.88--2.05)    0.176              1.10 (0.72--1.68)    0.644
  Health VAS, good vs. poor                1.79 (1.03--3.10)    0.04               1.64 (0.98--2.73)    0.06
  Activity limitation (HAQ DI)                                                                          
  Moderate vs. low                         3.10 (2.01--4.78)    \< 0.0001          1.60 (1.04--2.48)    0.033
  High vs. low                             7.14 (4.19--12.19)   \< 0.0001          2.11 (1.28--3.47)    0.003
  Anxiety/depression (EQ‐5D)                                                                            
  Moderate vs. low                         1.50 (1.13--2.01)    0.006              1.31 (1.01--1.69)    0.039
  High vs. low                             3.56 (1.33--9.56)    0.012              2.68 (1.31--5.49)    0.007
  Self‐efficacy for exercise (ESES)                                                                     
  Moderate vs. low                         0.87 (0.63--1.22)    0.422              0.90 (0.67--1.20)    0.458
  High vs. low                             0.53 (0.38--0.76)    0.001              0.87 (0.63--1.19)    0.373
  Current HEPA (IPAQ), yes vs. no          0.54 (0.41--0.72)    \< 0.0001          0.70 (0.55--0.89)    0.004
  Maintained HEPA (ESAI), yes vs. no       0.60 (0.37--0.96)    0.033              0.88 (0.55--1.40)    0.597

OR = odds ratio; 95% CI = 95% confidence interval; VAS = visual analog scale; HAQ DI = Health Assessment Questionnaire disability index; EQ‐5D = EuroQoL 5‐domain questionnaire; ESES = Exercise Self‐Efficacy Scale; HEPA = health‐enhancing physical activity; IPAQ = International Physical Activity Questionnaire; ESAI = Exercise Stage Assessment Instrument.
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Discussion {#acr23419-sec-0014}
==========

To our knowledge, this is the first study using longitudinal data to describe trajectories of fear‐avoidance beliefs on physical activity in a large well‐defined sample of people with RA. Three stable trajectories with low, moderate, and high levels of fear avoidance beliefs were identified. The most consistent predictors of high fear‐avoidance were high activity limitation, male sex, income below average, not currently performing HEPA, and elevated levels of anxiety/depression.

The smallest trajectory group was the one with high fear‐avoidance beliefs, indicating that most people with RA manage their disease without developing high levels of fear‐avoidance. Cross‐sectional analyses of baseline data in this same cohort indicated similar results [23](#acr23419-bib-0023){ref-type="ref"}, reporting a median of 7 on FABQ‐PA (range 0--24). The results also align with research on patients with nonspecific musculoskeletal pain, demonstrating that the majority recover and return to activity and work, while approximately 10--15% of patients with acute low‐back pain develop a persistent disabling condition [44](#acr23419-bib-0044){ref-type="ref"}, mediated mainly by psychological variables such as fear‐avoidance beliefs [45](#acr23419-bib-0045){ref-type="ref"}.

The stability of trajectories in the present study is in line with a previous 3‐year longitudinal study on patients with nonspecific low‐back pain [46](#acr23419-bib-0046){ref-type="ref"}, indicating that once fear‐avoidance beliefs have been established, they are not likely to dissolve automatically. For health professionals, it is thus important not only to assess physical function, but also to identify and challenge unhelpful negative cognitions about physical activity as potentially causing pain and injury. Since there is evidence for graded exposure treatment to reduce fear‐avoidance in long‐term back pain [17](#acr23419-bib-0017){ref-type="ref"}, [18](#acr23419-bib-0018){ref-type="ref"}, [19](#acr23419-bib-0019){ref-type="ref"}, future studies are motivated to evaluate its feasibility and outcome in patients with RA. In addition, the effectiveness of person‐centered, progressive resistance exercise to reduce fear‐avoidance beliefs in patients with fibromyalgia [21](#acr23419-bib-0021){ref-type="ref"} may be applicable in RA as well.

High fear‐avoidance beliefs were predicted by a number of variables included in the theoretical fear‐avoidance model developed by Lethem et al [15](#acr23419-bib-0015){ref-type="ref"} and Vlaeyen and Linton [16](#acr23419-bib-0016){ref-type="ref"}. The model describes a vicious circle where each variable influences, but is also influenced by, other variables in a circular chain. Among those, the strongest predictor in our study was activity limitation. The correlation between activity limitation and fear‐avoidance beliefs has been confirmed in a recent review of studies on patients with low‐back pain, concluding that fear‐avoidance has a prognostic value for poor outcome [13](#acr23419-bib-0013){ref-type="ref"}. However, the results in this review were valid only in subacute pain (duration from 2 weeks to 3 months) and not in people with pain of longer duration [13](#acr23419-bib-0013){ref-type="ref"}. The review results are to be compared with the results in our study, where 18% of the sample with RA and long‐term pain reported stable, high fear‐avoidance beliefs. Differences in attributions of pain may explain the differences, i.e., a subsample of people with RA may be strongly influenced by the awareness of inflammatory processes in their joints and tend to manage by avoiding physical activity.

Low physical activity levels, i.e., not performing current HEPA, were a predictor identified in the present study, representing a behavioral component in the fear‐avoidance model. Furthermore, this finding is in line with studies on patients with low‐back pain [47](#acr23419-bib-0047){ref-type="ref"}, while it is contradicted by the results in previous cross‐sectional studies on people with RA [24](#acr23419-bib-0024){ref-type="ref"}, [25](#acr23419-bib-0025){ref-type="ref"}, possibly due to differences in samples and methods.

Anxiety and depression predicted high fear‐avoidance beliefs in the present study and are also included as key constructs in the theoretical fear‐avoidance model. This finding is not surprising, as anxiety and depression are bidirectionally correlated with pain [48](#acr23419-bib-0048){ref-type="ref"}, a cardinal symptom in RA. Pain intensity was not a strong predictor in the present study but still contributed significantly, in line with previous studies on people with RA [23](#acr23419-bib-0023){ref-type="ref"}, [24](#acr23419-bib-0024){ref-type="ref"}. Research on low‐back pain has explored the link between perceived pain and physical injury, suggesting patients' uncertainty regarding diagnosis and the cause of pain explains more of the pain experience than the injury itself [28](#acr23419-bib-0028){ref-type="ref"}. Again, the differences in findings may be related to inflammation as a likely cause of pain in RA, whereas the physiologic triggers may not be as obvious in people with nonspecific long‐term pain.

A surprising finding, although previously reported in a cross‐sectional study of the present sample [23](#acr23419-bib-0023){ref-type="ref"}, was that male sex was a strong predictor of high fear‐avoidance beliefs. The reason for this sex difference is not clear, since women with RA are generally more affected by their disease and have more pain [49](#acr23419-bib-0049){ref-type="ref"}. Possibly traditional gender roles, with women being mainly responsible for daily household chores, necessitate early confrontation of pain and subsequent reduction of fear‐avoidance. However, this assumption has to be investigated further. Low income and education below university level predicted fear‐avoidance in the present study, which is supported by other studies identifying socioeconomic status as a consistent correlate of poor health [50](#acr23419-bib-0050){ref-type="ref"}. One possible explanation for these findings is that poor health literacy, with subsequent limited access to more complex information about disease and self‐management, is more frequent in groups with lower socioeconomic status [51](#acr23419-bib-0051){ref-type="ref"}. People with low education and low income may also more frequently have physically demanding jobs and a more sedentary leisure time [52](#acr23419-bib-0052){ref-type="ref"}, thus missing opportunities for nonsystematic exposure to physical activity in situations perceived as joyful.

There are methodologic limitations in this study that should be acknowledged when interpreting the results. It would have been interesting to include a sample representing all ages, severities of activity limitation, and physical activity levels. However, since data for the study were collected as part of recruitment for a physical activity intervention, our sample is not representative of the Swedish RA population most severely affected by their disease, but our proportion of women is representative, as is the age distribution [53](#acr23419-bib-0053){ref-type="ref"}. To further explore the links between fear‐avoidance, exercise, pain, and disability in an RA context, a more theory‐driven design would be desirable. Such a design should use data on inflammatory activity along with all variables included in the fear‐avoidance model, assess changes over time in all variables, and allow for analysis of mediators of change, e.g., in disability.

Missing data may have affected the results, but a robust method for imputation was used [54](#acr23419-bib-0054){ref-type="ref"}, and analyses performed both with and without imputation yielded similar results, indicating that the missingness did not bias our results. The present study cannot claim to fully explain the development of long‐term fear‐avoidance beliefs on physical activity. We recognize that there may be additional potential predictors of interest, such as catastrophizing thoughts and disease activity. Still, the study included a substantial number of variables according to a biopsychosocial approach and identified predictors of clinical relevance.

In conclusion, our results suggest that a small but significant group of people with RA hold stable, high fear‐avoidance beliefs about physical activity and may be at risk for entering into a deleterious circle of catastrophic thinking, avoidance of activities, and subsequent disuse, depression, and disability. High activity limitation, anxiety/depression, not being sufficiently physically active, and belonging to vulnerable socioeconomic groups predict high fear‐avoidance beliefs and should be considered by health professionals in their promotion of physical activity. Special attention should be given to men, as they are more likely to hold fear‐avoidance beliefs. Health professionals should assess not only medical aspects of RA but also psychological variables such as fear‐avoidance. Screening of negative pain‐related cognitions has long been included in clinical guidelines for the management of nonspecific back pain [55](#acr23419-bib-0055){ref-type="ref"} and may also be useful within rheumatology. Future studies are needed to investigate whether interventions, such as graded exposure and person‐centered progressive exercise, that are effective to reduce fear‐avoidance beliefs in other chronic conditions, are also feasible and beneficial to patients with RA.
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